XML 24 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2013
Fair Value Disclosures [Abstract]  
Assets and (liabilities) carried at fair value by hierarchy level
 
September 30, 2013
 
Total
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
Significant
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Assets accounted for at fair value on a recurring basis
 
 
 
 
Fixed maturities, AFS
 
 
 
 
ABS
$
1,115

$

$
942

$
173

CDOs
1,643


1,086

557

CMBS
2,438


1,968

470

Corporate
17,348


16,507

841

Foreign government/government agencies
1,179


1,133

46

Municipal
1,041


933

108

RMBS
2,663


1,743

920

U.S. Treasuries
2,314

55

2,259


Total fixed maturities
29,741

55

26,571

3,115

Fixed maturities, FVO
949


753

196

Equity securities, trading
11

11



Equity securities, AFS
385

200

127

58

Derivative assets
 
 
 
 
Credit derivatives
25


6

19

Equity derivatives
6



6

Foreign exchange derivatives
(50
)

(50
)

Interest rate derivatives
(27
)

(27
)

U.S. guaranteed minimum withdrawal benefit ("GMWB") hedging instruments
79


(18
)
97

U.S. macro hedge program
160



160

International program hedging instruments
84


91

(7
)
Other derivative contracts





Total derivative assets [1]
277


2

275

Short-term investments
2,262

324

1,938


Limited partnerships and other alternatives [2]
463


302

161

Reinsurance recoverable for U.S. GMWB and Japan GMWB, GMIB, and GMAB
(36
)

61

(97
)
Separate account assets [3]
136,447

98,149

37,563

735

Assets held for sale
2,211

1,732

471

8

Total assets accounted for at fair value on a recurring basis
$
172,710

$
100,471

$
67,788

$
4,451

Percentage of level to total
100
%
58
%
39
%
3
%
Liabilities accounted for at fair value on a recurring basis
 
 
 
 
Other policyholder funds and benefits payable
 
 
 
 
Guaranteed living benefits
$
(1,053
)
$

$

$
(1,053
)
Equity linked notes
(13
)


(13
)
Total other policyholder funds and benefits payable
(1,066
)


(1,066
)
Derivative liabilities
 
 
 
 
Credit derivatives
(16
)


(16
)
Equity derivatives
13


(1
)
14

Foreign exchange derivatives
(206
)

(206
)

Interest rate derivatives
(337
)

(311
)
(26
)
U.S. GMWB hedging instruments
79


(43
)
122

U.S. macro hedge program
21



21

International program hedging instruments
(277
)

(113
)
(164
)
Total derivative liabilities [4]
(723
)

(674
)
(49
)
Consumer notes [5]
(1
)


(1
)
Liabilities held for sale
(31
)


(31
)
Total liabilities accounted for at fair value on a recurring basis
$
(1,821
)
$

$
(674
)
$
(1,147
)
3. Fair Value Measurements (continued)
 
December 31, 2012
 
Total
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
Significant
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Assets accounted for at fair value on a recurring basis
 
 
 
 
Fixed maturities, AFS
 
 
 
 
ABS
$
1,673

$

$
1,435

$
238

CDOs
2,160


1,437

723

CMBS
3,912


3,380

532

Corporate
30,979


29,639

1,340

Foreign government/government agencies
1,460


1,426

34

Municipal
1,998


1,829

169

RMBS
4,671


3,538

1,133

U.S. Treasuries
2,551

78

2,473


Total fixed maturities
49,404

78

45,157

4,169

Fixed maturities, FVO
1,010

6

805

199

Equity securities, trading
1,847

1,847



Equity securities, AFS
400

203

142

55

Derivative assets
 
 
 
 
Credit derivatives
(10
)


(10
)
Equity derivatives
30



30

Foreign exchange derivatives
104


104


Interest rate derivatives
108


144

(36
)
U.S. GMWB hedging instruments
36


(53
)
89

U.S. macro hedge program
186



186

International program hedging instruments
127


142

(15
)
Total derivative assets [1]
581


337

244

Short-term investments
2,354

242

2,112


Limited partnerships and other alternative investments [2]
414


264

150

Reinsurance recoverable for U.S. GMWB and Japan GMWB, GMIB, and GMAB
1,081



1,081

Separate account assets [3]
138,497

97,976

39,938

583

Total assets accounted for at fair value on a recurring basis
$
195,588

$
100,352

$
88,755

$
6,481

Percentage of level to total
100
%
52
%
45
%
3
%
Liabilities accounted for at fair value on a recurring basis
 
 
 
 
Other policyholder funds and benefits payable
 
 
 
 
Guaranteed living benefits
$
(3,119
)
$

$

$
(3,119
)
Equity linked notes
(8
)


(8
)
Total other policyholder funds and benefits payable
(3,127
)


(3,127
)
Derivative liabilities
 
 
 
 
Credit derivatives
(6
)

(20
)
14

Equity derivatives
15



15

Foreign exchange derivatives
(17
)

(17
)

Interest rate derivatives
(359
)

(338
)
(21
)
U.S. GMWB hedging instruments
536


106

430

U.S. macro hedge program
100



100

International program hedging instruments
(231
)

(171
)
(60
)
Total derivative liabilities [4]
38


(440
)
478

Consumer notes [5]
(2
)


(2
)
Total liabilities accounted for at fair value on a recurring basis
$
(3,091
)
$

$
(440
)
$
(2,651
)
[1]
Includes over-the-counter("OTC") and OTC-cleared derivative instruments in a net asset value position after consideration of the impact of collateral posting requirements which may be imposed by agreements, clearing house rules and applicable law. At September 30, 2013 and December 31, 2012, $89 and $92, respectively, was the amount of cash collateral liability that was netted against the derivative asset value on the Condensed Consolidated Balance Sheet, and is excluded from the table above. For further information on derivative liabilities, see footnote 4 below.
[2]
Represents hedge funds where investment company accounting has been applied to a wholly-owned fund of funds measured at value.
[3]
As of September 30, 2013 and December 31, 2012, excludes approximately $3.4 billion and $3.1 billion, respectively, of investment sales receivable that are not subject to fair value accounting.
[4]
Includes over-the-counter derivative instruments in a net negative market value position (derivative liability). In the Level 3 roll forward table included below in this Note, the derivative asset and liability are referred to as “freestanding derivatives” and are presented on a net basis.
[5]
Represents embedded derivatives associated with non-funding agreement-backed consumer equity-linked notes.
Information about significant unobservable inputs used in Level 3 assets measured at fair value
 
As of September 30, 2013
Securities
 
 
 
Unobservable Inputs
 
Assets accounted for at fair value on a recurring basis
Fair
Value
Predominant
Valuation
Method
Significant Unobservable Input
Minimum
Maximum
Weighted Average [1]
Impact of
Increase in Input
on Fair Value [2]
CMBS
$
470

Discounted cash flows
Spread (encompasses
prepayment, default risk and loss severity)
67bps
2,615bps
624bps
Decrease
Corporate [3]
431

Discounted cash flows
Spread
175bps
5,014bps
388bps
Decrease
Municipal
108

Discounted cash flows
Spread
192bps
290bps
229bps
Decrease
RMBS
920

Discounted cash flows
Spread
64bps
1,992bps
284bps
Decrease
 
 
 
Constant prepayment rate
0.0
%
10.0
%
2.0
%
Decrease [4]
 
 
 
Constant default rate
1.0
%
17.0
%
8.0
%
Decrease
 
 
 
Loss severity
%
100.0
%
79.0
%
Decrease
 
As of December 31, 2012
CMBS
$
532

Discounted cash flows
Spread (encompasses
prepayment, default risk and loss severity)
320bps
3,615bps
1,013bps
Decrease
Corporate [3]
888

Discounted cash flows
Spread
145bps
900bps
333bps
Decrease
Municipal
169

Discounted cash flows
Spread
227bps
344bps
254bps
Decrease
RMBS
1,133

Discounted cash flows
Spread
54bps
1,689bps
379bps
Decrease
 
 
 
Constant prepayment rate
0.0
%
12.0
%
2.0
%
Decrease [4]
 
 
 
Constant default rate
1.0
%
24.0
%
8.0
%
Decrease
 
 
 
Loss severity
%
100.0
%
80.0
%
Decrease
[1]
The weighted average is determined based on the fair value of the securities.
[2]
Conversely, the impact of a decrease in input would have the opposite impact to the fair value as that presented in the table above.
[3]
Level 3 corporate securities excludes those for which the Company bases fair value on broker quotations as discussed below.
[4]
Decrease for above market rate coupons and increase for below market rate coupons.
Information about significant unobservable inputs used in Level 3 derivative instruments measured at fair value
 
As of September 30, 2013
Freestanding Derivatives
 
 
 
Unobservable Inputs
 
  
Fair
Value
Predominant Valuation
Method
Significant
Unobservable Input
Minimum
Maximum
Impact of
Increase in Input
on Fair Value [1]
Interest rate derivative
 
 
 
 
 
 
Interest rate swaps
(26
)
Discounted  cash flows
Swap curve 
beyond 30 years
3.4%
3.4%
Increase
U.S. GMWB hedging instruments
 
 
 
 
 
 
Equity options
108

Option model
Equity volatility
21%
36%
Increase
Customized swaps
111

Discounted  cash flows
Equity volatility
10%
50%
Increase
U.S. macro hedge program
 
 
 
 
 
 
Equity options
181

Option model
Equity volatility
22%
34%
Increase
International hedging program
 
 
 
 
 
 
Equity options
(171
)
Option model
Equity volatility
29%
39%
Increase
 
As of December 31, 2012
Equity derivatives
 
 
 
 
 
 
Equity options
$
45

Option model
Equity volatility
13%
24%
Increase
Interest rate derivative
 
 
 
 
 
 
Interest rate swaps
(57
)
Discounted  cash flows
Swap curve 
beyond 30 years
2.8%
2.8%
Increase
U.S. GMWB hedging instruments
 
 
 
 
 
 
Equity options
281

Option model
Equity volatility
10%
31%
Increase
Customized swaps
238

Discounted  cash flows
Equity volatility
10%
50%
Increase
U.S. macro hedge program
 
 
 
 
 
 
Equity options
286

Option model
Equity volatility
24%
43%
Increase
International hedging program
 
 
 
 
 
 
Equity options
44

Option model
Equity volatility
22%
33%
Increase
Long interest rate
(119
)
Option model
Interest rate volatility
—%
1%
Increase
[1]
 Conversely, the impact of a decrease in input would have the opposite impact to the fair value as that presented in the table. Changes are based on long positions, unless otherwise noted. Changes in fair value will be inversely impacted for short positions.
Information about significant unobservable inputs used in Level 3 living benefits measured at fair value
 
Unobservable Inputs
Significant Unobservable Input
Minimum
Maximum
Impact of Increase in  Input
on Fair Value Measurement [1]
Withdrawal Utilization[2]
20%
100%
Increase
Withdrawal Rates [2]
—%
8%
Increase
Annuitization utilization [3]
—%
100%
Increase
Lapse Rates [4]
—%
75%
Decrease
Reset Elections [5]
20%
75%
Increase
Equity Volatility [6]
10%
50%
Increase
[1]
Conversely, the impact of a decrease in input would have the opposite impact to the fair value as that presented in the table.
[2]
Ranges represent assumed cumulative percentages of policyholders taking withdrawals and the annual amounts withdrawn.
[3]
For reinsurance associated with Japan GMIB, range represents assumed cumulative percentages of policyholders annuitizing variable annuity contracts.
[4]
Range represents assumed annual percentages of full surrender of the underlying variable annuity contracts across all policy durations for in force business.
[5]
Range represents assumed cumulative percentages of policyholders that would elect to reset their guaranteed benefit base.
[6]
Range represents implied market volatilities for equity indices based on multiple pricing sources.
Roll-forward of Financial Instruments Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3)
  
Fixed Maturities, AFS
Fixed
Maturities,
FVO
Assets
ABS
CDOs
CMBS
Corporate
Foreign
govt./govt.
agencies
Municipal
RMBS
Total Fixed
Maturities,
AFS
Fair value as of June 30, 2013
$
169

$
629

$
485

$
813

$
44

$
109

$
971

$
3,220

$
197

Total realized/unrealized gains (losses)
 
 
 
 
 
 
 
 
 
Included in net income [1], [2]


(9
)
(2
)


(2
)
(13
)
(1
)
Included in OCI [3]
1

3

33

5


(1
)
(3
)
38


Purchases
5

4

17

23

3


29

81

3

Settlements
(1
)
(50
)
(20
)
(2
)
(1
)

(36
)
(110
)

Sales


(28
)
(3
)


(39
)
(70
)
(1
)
Transfers into Level 3 [4]


5

26




31


Transfers out of Level 3 [4]
(1
)
(29
)
(13
)
(19
)



(62
)
(2
)
Fair value as of September 30, 2013
$
173

$
557

$
470

$
841

$
46

$
108

$
920

$
3,115

$
196

Changes in unrealized gains (losses) included in net income related to financial instruments still held at September 30, 2013 [2] [7]
$

$

$
(4
)
$
(2
)
$

$

$
(4
)
$
(10
)
$
(1
)
 3. Fair Value Measurements (continued)
 
 
Freestanding Derivatives [5]
Assets (Liabilities)
Equity
Securities,
AFS
Credit
Equity
Interest
Rate
U.S.
GMWB
Hedging
U.S.
Macro
Hedge
Program
Intl.
Program
Hedging
Other derivative contracts
Total Free-
Standing
Derivatives
[5]
Fair value as of June 30, 2013
$
62

$
3

$
25

$
(51
)
$
329

$
209

$
(116
)
$
(20
)
$
379

Total realized/unrealized gains (losses)
 
 
 
 
 
 
 

 
Included in net income [1], [2]
(4
)

(6
)
1

(109
)
(39
)
(65
)

(218
)
Included in OCI [3]









Purchases


1



11

(4
)

8

Settlements




(1
)

42


41

Sales









Transfers into Level 3 [4]









Transfers out of Level 3 [4]



24



(28
)
20

16

Fair value as of September 30, 2013
$
58

$
3

$
20

$
(26
)
$
219

$
181

$
(171
)
$

$
226

Changes in unrealized gains (losses) included in net income related to financial instruments still held at September 30, 2013 [2] [7]
$
(4
)
$

$
(5
)
$
1

$
(111
)
$
(39
)
$
(47
)
$

$
(201
)
Assets
Limited Partnerships and Other Alternative Investments
Reinsurance Recoverable for U.S. GMWB
and Japan
GMWB, GMIB, 
and GMAB [6]
Assets held for Sale
Separate
Accounts
Fair value as of June 30, 2013
$
174

$
225

$
5

$
820

Transfers to assets held for sale




Total realized/unrealized gains (losses)
 
 
 
 
Included in net income [1], [2]
(10
)
(405
)
5

(9
)
Included in OCI [3]

6



Purchases
17



(19
)
Settlements

77

(2
)

Sales



(35
)
Transfers into Level 3 [4]



35

Transfers out of Level 3 [4]
(20
)


(57
)
Fair value as of September 30, 2013
$
161

$
(97
)
$
8

$
735

Changes in unrealized gains (losses) included in net income related to financial instruments still held at September 30, 2013 [2] [7]
$
(10
)
$
(405
)
$
5

$
3

 
Other Policyholder Funds and Benefits Payable
 
 
Liabilities
Guaranteed
Living
Benefits [7]
Equity Linked
Notes
Total Other
Policyholder Funds
and Benefits Payable
Liabilities Held for Sale
Consumer
Notes
Fair value as of June 30, 2013
$
(1,676
)
$
(12
)
$
(1,688
)
$
(28
)
$
(1
)
Transfers to liabilities held for sale





Total realized/unrealized gains (losses)
 
 
 
 
 
Included in net income [1], [2]
677

(1
)
676



Included in OCI [3]
(9
)

(9
)
(2
)

Settlements
(45
)

(45
)
(1
)

Fair value as of September 30, 2013
$
(1,053
)
$
(13
)
$
(1,066
)
$
(31
)
$
(1
)
Changes in unrealized gains (losses) included in net income related to financial instruments still held at September 30, 2013 [2] [7]
$
677

$
(1
)
$
676

$

$

3. Fair Value Measurements (continued)
The tables below provide a fair value roll forward for the nine months ended September 30, 2013, for Level 3 financial instruments.
  
Fixed Maturities, AFS
Fixed
Maturities,
FVO
Assets
ABS
CDOs
CMBS
Corporate
Foreign
govt./govt.
agencies
Municipal
RMBS
Total Fixed
Maturities,
AFS
Fair value as of January 1, 2013
$
238

$
723

$
532

$
1,340

$
34

$
169

$
1,133

$
4,169

$
199

Total realized/unrealized gains (losses)
 
 
 
 
 
 
 
 
 
Included in net income [1], [2]

(11
)
(11
)
12

1


27

18

8

Included in OCI [3]
16

101

66

(18
)
(5
)
(10
)
34

184


Purchases
21

30

30

68

27


61

237

12

Settlements
(5
)
(85
)
(65
)
(65
)
(3
)

(104
)
(327
)
(1
)
Sales
(83
)
(195
)
(97
)
(300
)
(6
)
(51
)
(231
)
(963
)
(22
)
Transfers into Level 3 [4]

23

35

85




143

3

Transfers out of Level 3 [4]
(14
)
(29
)
(20
)
(281
)
(2
)


(346
)
(3
)
Fair value as of September 30, 2013
$
173

$
557

$
470

$
841

$
46

$
108

$
920

$
3,115

$
196

Changes in unrealized gains (losses) included in net income related to financial instruments still held at September 30, 2013 [2] [7]
$
(4
)
$

$
(5
)
$
(4
)
$

$

$
(5
)
$
(18
)
$
28

 
 
Freestanding Derivatives [5]
Assets (Liabilities)
Equity
Securities,
AFS
Credit
Equity
Interest
Rate
U.S.
GMWB
Hedging
U.S.
Macro
Hedge
Program
Intl.
Program
Hedging
Other derivative contracts
Total Free-
Standing
Derivatives
[5]
Fair value as of January 1, 2013
$
55

$
4

$
45

$
(57
)
$
519

$
286

$
(75
)
$

$
722

Total realized/unrealized gains (losses)
 
 
 
 
 
 
 
 
 
Included in net income [1], [2]
(8
)

(23
)
5

(299
)
(139
)
(149
)

(605
)
Included in OCI [3]
6

 
 
 
 
 
 

 
Purchases
7


1



34

(29
)

6

Settlements

(1
)
(3
)

(1
)

54


49

Sales
(2
)








Transfers into Level 3 [4]







(20
)
(20
)
Transfers out of Level 3 [4]



26



28

20

74

Fair value as of September 30, 2013
$
58

$
3

$
20

$
(26
)
$
219

$
181

$
(171
)
$

$
226

Changes in unrealized gains (losses) included in net income related to financial instruments still held at September 30, 2013 [2] [7]
$
(7
)
$

$
(21
)
$

$
(296
)
$
(136
)
$
(75
)
$

$
(528
)
 

3. Fair Value Measurements (continued)
Assets
Limited Partnerships and Other Alternative Investments
Reinsurance Recoverable for U.S. GMWB
and Japan
GMWB, GMIB, 
and GMAB [6]
Assets held for Sale
Separate
Accounts
Fair value as of January 1, 2013
$
150

$
1,081

$

$
583

Transfers to assets held for sale

(12
)
12


Total realized/unrealized gains (losses)
 
 
 
 
Included in net income [1], [2]
(8
)
(1,241
)
3

7

Included in OCI [3]

(164
)


Purchases
59



240

Settlements

239

(7
)
(1
)
Sales
(9
)



(66
)
Transfers into Level 3 [4]



39

Transfers out of Level 3 [4]
(31
)


(67
)
Fair value as of September 30, 2013
$
161

$
(97
)
$
8

$
735

Changes in unrealized gains (losses) included in net income related to financial instruments still held at September 30, 2013 [2] [7]
$
(8
)
$
(1,241
)
$
3

$
15

 
Other Policyholder Funds and Benefits Payable
 
 
Liabilities
Guaranteed
Living
Benefits [7]
Equity Linked
Notes
Total Other
Policyholder Funds
and Benefits Payable
Liabilities Held for Sale
Consumer
Notes
Fair value as of January 1, 2013
$
(3,119
)
$
(8
)
$
(3,127
)
$

$
(2
)
Transfers to liabilities held for sale
43


43

(43
)

Total realized/unrealized gains (losses)
 
 
 
 
 
Included in net income [1], [2]
1,936

(5
)
1,931

14

1

Included in OCI [3]
197


197

1


Settlements [8]
(110
)

(110
)
(3
)

Fair value as of September 30, 2013
$
(1,053
)
$
(13
)
$
(1,066
)
$
(31
)
$
(1
)
Changes in unrealized gains (losses) included in net income related to financial instruments still held at September 30, 2013 [2] [7]
$
1,936

$
(5
)
$
1,931

$
14

$
1

The tables below provide a fair value roll forward for the three months ended September 30, 2012, for Level 3 financial instruments.
 
Fixed Maturities, AFS
 
Assets
ABS
CDOs
CMBS
Corporate
Foreign
govt./govt.
agencies
Municipal
RMBS
Total Fixed
Maturities,
AFS
Fixed
Maturities,
FVO
Fair value as of June 30, 2012
$
269

$
685

$
610

$
1,221

$
42

$
506

$
1,035

$
4,368

$
482

Total realized/unrealized gains (losses)
 
 
 
 
 
 
 
 
 
Included in net income [1], [2]
1

(6
)
(7
)
(5
)

(4
)
(17
)
(38
)
32

Included in OCI [3]
8

37

17

(29
)

13

145

191


Purchases
6


7

15

2


41

71


Settlements
(4
)
(6
)
(22
)
(1
)
(1
)

(33
)
(67
)

Sales
(9
)

(74
)
(6
)
(10
)
(22
)
(53
)
(174
)

Transfers into Level 3 [4]
9


11

179



2

201


Transfers out of Level 3 [4]
(12
)


(28
)

(303
)
(23
)
(366
)

Fair value as of September 30, 2012
$
268

$
710

$
542

$
1,346

$
33

$
190

$
1,097

$
4,186

$
514

Changes in unrealized gains (losses) included in net income related to financial instruments still held at September 30, 2012 [2] [7]
$
1

$
(6
)
$
(7
)
$
(4
)
$

$
(4
)
$
(17
)
$
(37
)
$
32

3. Fair Value Measurements (continued)
 
 
Freestanding Derivatives [5]
Assets (Liabilities)
Equity
Securities,
AFS
Credit
Equity
Interest
Rate
U.S.
GMWB
Hedging
U.S.
Macro
Hedge
Program
Intl.
Program
Hedging
Total Free-
Standing
Derivatives [5]
Fair value as of June 30, 2012
$
57

$
(388
)
$
43

$
(91
)
$
756

$
180

$
(55
)
$
445

Total realized/unrealized gains (losses)
 
 
 
 
 
 
 
 
Included in net income [1], [2]
(2
)
49

(12
)
1

(159
)
(98
)
(79
)
(298
)
Included in OCI [3]








Purchases
2


24

1

19


15

59

Settlements

59





17

76

Sales
(1
)







Transfers out of Level 3 [4]



31




31

Fair value as of September 30, 2012
$
56

$
(280
)
$
55

$
(58
)
$
616

$
82

$
(102
)
$
313

Changes in unrealized gains (losses) included in net income related to financial instruments still held at September 30, 2012 [2] [7]
$
(2
)
$
25

$
(10
)
$
1

$
(159
)
$
(98
)
$
(51
)
$
(292
)
Assets
Reinsurance Recoverable for U.S. GMWB
and Japan
GMWB, GMIB, 
and GMAB [6]
Separate Accounts
Fair value as of June 30, 2012
$
2,662

$
1,335

Total realized/unrealized gains (losses)
 
 
Included in net income [1], [2]
(916
)
(2
)
Included in OCI [3]
67


Purchases

97

Settlements
98


Sales

(41
)
Transfers into Level 3 [4]

(3
)
Transfers out of Level 3 [4]

(7
)
Fair value as of September 30, 2012
$
1,911

$
1,379

Changes in unrealized gains (losses) included in net income related to financial instruments still held at September 30, 2012 [2] [7]
$
(916
)
$
8

 
Other Policyholder Funds and Benefits Payable [1]
 
 
Liabilities
Guaranteed
Living
Benefits [7]
Equity Linked
Notes
Total Other
Policyholder Funds
and Benefits Payable
Other
Liabilities
Consumer
Notes
Fair value as of June 30, 2012
$
(5,143
)
$
(10
)
$
(5,153
)
$
(29
)
$
(4
)
Total realized/unrealized gains (losses)
 
 
 
 
 
Included in net income [1], [2]
1,176


1,176

(14
)
2

Included in OCI [3]
(76
)

(76
)


Settlements
(65
)

(65
)


Fair value as of September 30, 2012
$
(4,108
)
$
(10
)
$
(4,118
)
$
(43
)
$
(2
)
Changes in unrealized gains (losses) included in net income related to financial instruments still held at September 30, 2012 [2] [7]
$
1,176

$

$
1,176

$
(14
)
$
2

3. Fair Value Measurements (continued)
The tables below provide a fair value roll forward for the nine months ended September 30, 2012, for Level 3 financial instruments.
 
Fixed Maturities, AFS
 
Assets
ABS
CDOs
CMBS
Corporate
Foreign
govt./govt.
agencies
Municipal
RMBS
Total Fixed
Maturities,
AFS
Fixed
Maturities,
FVO
Fair value as of January 1, 2012
$
317

$
328

$
348

$
1,497

$
37

$
382

$
933

$
3,842

$
484

Total realized/unrealized gains (losses)
 
 
 
 
 
 
 
 
 
Included in net income [1], [2]

(8
)
(30
)
(8
)

(4
)
(6
)
(56
)
53

Included in OCI [3]
39

98

57

(44
)
1

31

193

375


Purchases
18


18

141

8

174

253

612


Settlements
(40
)
(24
)
(66
)
(39
)
(3
)

(92
)
(264
)

Sales
(21
)
(1
)
(108
)
(39
)
(10
)
(82
)
(163
)
(424
)
(23
)
Transfers into Level 3 [4]
9

317

398

438



2

1,164


Transfers out of Level 3 [4]
(54
)

(75
)
(600
)

(311
)
(23
)
(1,063
)

Fair value as of September 30, 2012
$
268

$
710

$
542

$
1,346

$
33

$
190

$
1,097

$
4,186

$
514

Changes in unrealized gains (losses) included in net income related to financial instruments still held at September 30, 2012 [2] [7]
$
(1
)
$
(8
)
$
(3
)
$
(4
)
$

$
(4
)
$
1

$
(19
)
$
61

 
 
Freestanding Derivatives [5]
Assets (Liabilities)
Equity
Securities,
AFS
Credit
Equity
Interest
Rate
U.S.
GMWB
Hedging
U.S.
Macro
Hedge
Program
Intl.
Program
Hedging
Total Free-
Standing
Derivatives [5]
Fair value as of January 1, 2012
$
56

$
(489
)
$
36

$
(91
)
$
883

$
357

$
(35
)
$
661

Total realized/unrealized gains (losses)
 
 
 
 
 
 
 
 
Included in net income [1], [2]
2

153

(24
)
1

(332
)
(275
)
(64
)
(541
)
Included in OCI [3]
(2
)







Purchases
10


59

1

42


(64
)
38

Settlements

56

(16
)



53

93

Sales
(10
)







Transfers out of Level 3 [4]



31

23


8

62

Fair value as of September 30, 2012
$
56

$
(280
)
$
55

$
(58
)
$
616

$
82

$
(102
)
$
313

Changes in unrealized gains (losses) included in net income related to financial instruments still held at September 30, 2012 [2] [7]
$
2

$
122

$
(11
)
$
1

$
(332
)
$
(274
)
$
(37
)
$
(531
)
3. Fair Value Measurements (continued)
Assets
Reinsurance Recoverable for U.S. GMWB
and Japan
GMWB, GMIB, 
and GMAB [6]
Separate Accounts
Fair value as of January 1, 2012
$
3,073

$
1,031

Total realized/unrealized gains (losses)
 
 
Included in net income [1], [2]
(1,429
)
31

Included in OCI [3]
(23
)

Purchases

336

Settlements
290

(1
)
Sales

(442
)
Transfers into Level 3 [4]

451

Transfers out of Level 3 [4]

(27
)
Fair value as of September 30, 2012
$
1,911

$
1,379

Changes in unrealized gains (losses) included in net income related to financial instruments still held at September 30, 2012 [2] [7]
$
(1,429
)
$
18

 
Other Policyholder Funds and Benefits Payable [1]
 
 
Liabilities
Guaranteed
Living
Benefits [7]
Equity Linked
Notes
Total Other
Policyholder Funds
and Benefits Payable
Other
Liabilities
Consumer
Notes
Fair value as of January 1, 2012
$
(5,776
)
$
(9
)
$
(5,785
)
$
(9
)
$
(4
)
Total realized/unrealized gains (losses)
 
 
 
 
 
Included in net income [1], [2]
1,847

(1
)
1,846

(34
)
2

Included in OCI [3]
26


26



Settlements
(205
)

(205
)


Fair value as of September 30, 2012
$
(4,108
)
$
(10
)
$
(4,118
)
$
(43
)
$
(2
)
Changes in unrealized gains (losses) included in net income related to financial instruments still held at September 30, 2012 [2] [7]
$
1,847

$
(1
)
$
1,846

$
(34
)
$
2

[1]
The Company classifies gains and losses on GMWB reinsurance derivatives and Guaranteed Living Benefit embedded derivatives as unrealized gains (losses) for purposes of disclosure in this table because it is impracticable to track on a contract-by-contract basis the realized gains (losses) for these derivatives and embedded derivatives.
[2]
All amounts in these rows are reported in net realized capital gains (losses). The realized/unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on net income for the Company. All amounts are before income taxes and amortization of DAC.
[3]
All amounts are before income taxes and amortization of DAC.
[4]
Transfers in and/or (out) of Level 3 are primarily attributable to the availability of market observable information and the re-evaluation of the observability of pricing inputs.
[5]
Derivative instruments are reported in this table on a net basis for asset/(liability) positions and reported in the Condensed Consolidated Balance Sheet in other investments and other liabilities.
[6]
Includes fair value of reinsurance recoverables of approximately $148 and $1.7 billion as of September 30, 2013 and 2012, respectively, related to a transaction entered into with an affiliated captive reinsurer. See Note 11 - Transactions with Affiliates of Notes to Condensed Consolidated Financial Statements for more information.
[7]
Includes both market and non-market impacts in deriving realized and unrealized gains (losses).
Fair value of assets and liabilities accounted for using the fair value option
 
Three Months Ended September 30,
Nine Months Ended September 30,
 
2013
2012
2013
2012
Assets
 
 
 
 
Fixed maturities, FVO
 
 
 
 
Corporate
$
1

$
6

$
(12
)
$
6

CRE CDOs

18

3

27

Foreign government
8

13

(77
)
(16
)
Other liabilities
 
 
 
 
Credit-linked notes

(14
)

(34
)
Total realized capital gains (losses)
$
9

$
23

$
(86
)
$
(17
)
Fair value of assets and liabilities accounted for using the fair value option
 
As of
 
September 30, 2013
December 31, 2012
Assets
 
 
Fixed maturities, FVO
 
 
ABS
$
3

$

Corporate
79

108

CDO
186

193

CMBS
8

4

Foreign government
650

699

Municipals
1

1

RMBS
5

3

U.S. Government
17

2

Total fixed maturities, FVO
$
949

$
1,010


Financial Instruments Not Carried at Fair Value
 
September 30, 2013
December 31, 2012
 
Fair Value Hierarchy Level
Carrying Amount
Fair Value
Carrying Amount
Fair Value
Assets
 
 
 
 
 
Policy loans
Level 3
1,410

1,478

1,951

2,112

Mortgage loans
Level 3
3,552

3,591

4,935

5,109

Liabilities
 
 
 
 
 
Other policyholder funds and benefits payable [1]

Level 3
9,224

9,433

9,318

9,668

Consumer notes [2]

Level 3
81

82

159

159

[1]
Excludes group accident and health and universal life insurance contracts, including corporate owned life insurance.
[2]
Excludes amounts carried at fair value and included in disclosures above.